Literature DB >> 20195958

Altered expression of genes profiles modulated by a combination of Astragali Radix and Angelicae Sinensis Radix in obstructed rat kidney.

Liqiang Meng1, Vicki Van Putten, Lei Qu, Raphael A Nemenoff, Ming-Ying Shang, Shao-Qing Cai, Xiaomei Li.   

Abstract

The decoction of a combination of two Chinese herbs, Astragali Radix (the roots of Astragalus membranaceus var. mongholicus) and Angelicae Sinensis Radix (the roots of Angelica sinensis), here named as A&A, has been demonstrated to have renoprotective effects in several animal models and may be considered as a complementary therapeutic medicine for chronic kidney disease. In this study, genomic approaches were employed to identify expression signatures in the obstructed kidney, which may be linked to the molecular actions associated with anti-fibrotic effects of A&A. Ninety-six male Wistar rats were divided randomly into sham, SAA (sham + A&A), UUO (unilateral ureteral obstruction), and UAA (UUO + A&A) groups. The rats in the SAA and UAA groups were administered A&A (14 g/kg) by oral gavage once daily; the ones in the sham and UUO groups were given equal volumes of water. Eight rats from each group were sacrificed at days 3, 7, and 10 after the operation, respectively. Changes in gene expression in the kidneys were determined using Affymetrix RAE-230A GeneChips. The differential expression of known genes between UAA and UUO was confirmed by RT-PCR. The results revealed that 40, 65, and 104 genes were upregulated and 30, 36, and 40 genes downregulated in UUO compared with the sham group at days 3, 7, and 10, respectively. Compared to the UUO group, eight genes were upregulated and two genes were downregulated at day 3 in the UAA group, and two genes were upregulated at day 10. These genes included transient receptor protein 3 (TRP3), bone marrow stromal cell antigen 1 (BST-1), peroxisomal biogenesis factor 6 (PEX6), xanthine dehydrogenase (XDH), cytochrome P450 subfamily I member A1 (CYP1A1), serine/cysteine proteinase inhibitor clade E member1 (PAI-1), fibroblast growth factor 23 (FGF23), and five ESTs. Among these genes, differential expression of PAI-1, FGF23, and CYP1A1 were further confirmed by RT-PCR. These data provide the evidence that the anti-fibrotic effects of A&A are mediated through multiple pathways in obstructive nephropathy, and novel mechanisms may be involved in the increasing degeneration of ECM, decreasing ROS reaction, and regulation of the calcium-phosphate metabolism. © Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195958     DOI: 10.1055/s-0029-1240943

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  Astragaloside content in the periderm, cortex, and xylem of Astragalus membranaceus root.

Authors:  Ha-Jeong Kwon; Jeehyun Hwang; Sun-Kyoung Lee; Yong-Duk Park
Journal:  J Nat Med       Date:  2013-02-05       Impact factor: 2.343

2.  Efficacy and safety of the Fu-Zheng-Qu-Zhuo method on retarding the progress of chronic kidney disease (stage 3-4): a systematic review and meta-analysis.

Authors:  Shi-Yi Liu; Po Huang; Ning Zhang
Journal:  Ann Transl Med       Date:  2019-03

3.  Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.

Authors:  L Q Meng; J W Tang; Y Wang; J R Zhao; M Y Shang; M Zhang; S Y Liu; L Qu; S Q Cai; X M Li
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Bioactivities of major constituents isolated from Angelica sinensis (Danggui).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2011-08-19       Impact factor: 5.455

5.  Beneficial effects of Fu-Zheng-Qu-Zhuo oral liquid combined with standard integrated therapy in patients with chronic kidney disease (stage 3-4): A randomized placebo-controlled clinical trial.

Authors:  Shen Li; Xiang-Rong Rao; Xi-Wen Dai; Kun Pei; Lee Wang; Bao-Min Huo; Xiu-Juan Wang; Ling-Xin Kong; Nan-Nan Zhang; Feng-Mei Lian
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  Renoprotective Effect of a Chinese Herbal Formula, Qidan Dihuang Decoction, on Streptozotocin-Induced Diabetes in Rat.

Authors:  Z J Chen; F Ma; X M Sun; X S Zhao; R Luo
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-12       Impact factor: 2.629

7.  Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways.

Authors:  Hao Yuan; Xuelian Wu; Xiaomin Wang; Chengfu Yuan
Journal:  Genes Dis       Date:  2020-06-21

Review 8.  Promoting Plant-Based Therapies for Chronic Kidney Disease.

Authors:  Muhammad Ali Khan; Andrew J Kassianos; Wendy E Hoy; Ahm Khurshid Alam; Helen G Healy; Glenda C Gobe
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

9.  Induction of oxidative stress in kidney.

Authors:  Emin Ozbek
Journal:  Int J Nephrol       Date:  2012-04-17

Review 10.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.

Authors:  Yifei Zhong; Yueyi Deng; Yiping Chen; Peter Y Chuang; John Cijiang He
Journal:  Kidney Int       Date:  2013-07-17       Impact factor: 10.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.